752924-21-3 Usage
Uses
Used in Research Applications:
3-MeO-PCP is utilized as a research chemical for studying the effects of NMDA receptor binding on the brain and its potential implications in various neurological and psychiatric conditions. Its psychoactive and dissociative properties make it a valuable tool for understanding the mechanisms of action and potential therapeutic applications of similar compounds.
Used in Drug Development:
In the pharmaceutical industry, 3-MeO-PCP may be used as a starting point for the development of new drugs with improved safety profiles and therapeutic effects. By studying its interactions with the NMDA receptor and its psychoactive properties, researchers can work towards designing safer and more effective medications for the treatment of various disorders.
Used in Forensic Toxicology:
3-MeO-PCP is also used in forensic toxicology for the identification and analysis of controlled substances in biological samples. Its presence in samples can provide valuable information for legal and medical investigations, helping to determine the cause of drug-related incidents and support the enforcement of drug control regulations.
Check Digit Verification of cas no
The CAS Registry Mumber 752924-21-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,2,9,2 and 4 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 752924-21:
(8*7)+(7*5)+(6*2)+(5*9)+(4*2)+(3*4)+(2*2)+(1*1)=173
173 % 10 = 3
So 752924-21-3 is a valid CAS Registry Number.
752924-21-3Relevant academic research and scientific papers
DOPAMINE D2 RECEPTOR LIGANDS
-
Page/Page column 115; 117; 125; 126; 129; 130, (2016/07/05)
The present invention relates to novel dopamine D2 receptor ligands. The invention further relates to functionally-biased dopamine D2 receptor ligands and the use of these compounds for treating or preventing central nervous system and systemic disorders associated with dysregulation of dopaminergic activity.
